Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wagstaff, R.
Right arrow Articles by DiSepio, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagstaff, R.
Right arrow Articles by DiSepio, D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

High-Throughput Screening for Norepinephrine Transporter Inhibitors Using the FLIPRTetra

Ryan Wagstaff

Department of Pharmacology & Lead Discovery, Neurocrine Bisciences, Inc., San Diego, California

Michael Hedrick

Department of Pharmacology & Lead Discovery, Neurocrine Bisciences, Inc., San Diego, California

Jun Fan

Department of Discovery Biology, Neurocrine Biosciences, Inc., San Diego, California

Paul D. Crowe

Department of Pharmacology & Lead Discovery, Neurocrine Bisciences, Inc., San Diego, California, pcrowe{at}neurocrine.com

Daniel DiSepio

Johnson & Johnson, PRD, San Diego, California, Department of Pharmacology & Lead Discovery, Neurocrine Bisciences, Inc., San Diego, California

Monoamine transporters regulate the concentration of neurotransmitters in the synapse following neurotransmission and are very important drug targets in the pharmaceutical industry. Because of the labor-intensive nature of functional uptake assays using radioactive substrates, high-throughput screening for monoamine transporter inhibitors has been limited to radioligand binding assays. In this article, the authors describe the development of a 384-well, high-throughput functional screening assay for norepinephrine transporter inhibitors using the FLIPRTetra and a recently identified fluorescent substrate, 4-(4-dimethylaminostyryl)- N-methyl-pyridinium (ASP+). (Journal of Biomolecular Screening 2007:436-441)

Key Words: norepinephrine • transporter • FLIPRTetra • fluorescent substrate

Journal of Biomolecular Screening, Vol. 12, No. 3, 436-441 (2007)
DOI: 10.1177/1087057106297994
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Biomol ScreenHome page
M.J. Wigglesworth, K.J. Lawless, D.J. Standing, E.K. Mackenzie, V.R. Kitchen, F. Mckay, E. Ward, S.J. Brough, M. Stylianou, F.R. Jewitt, et al.
Use of Cryopreserved Cells for Enabling Greater Flexibility in Compound Profiling
J Biomol Screen, June 1, 2008; 13(5): 354 - 362.
[Abstract] [PDF]